» Articles » PMID: 22710039

The American Association for Thoracic Surgery Guidelines for Lung Cancer Screening Using Low-dose Computed Tomography Scans for Lung Cancer Survivors and Other High-risk Groups

Abstract

Objective: Lung cancer is the leading cause of cancer death in North America. Low-dose computed tomography screening can reduce lung cancer-specific mortality by 20%.

Method: The American Association for Thoracic Surgery created a multispecialty task force to create screening guidelines for groups at high risk of developing lung cancer and survivors of previous lung cancer.

Results: The American Association for Thoracic Surgery guidelines call for annual lung cancer screening with low-dose computed tomography screening for North Americans from age 55 to 79 years with a 30 pack-year history of smoking. Long-term lung cancer survivors should have annual low-dose computed tomography to detect second primary lung cancer until the age of 79 years. Annual low-dose computed tomography lung cancer screening should be offered starting at age 50 years with a 20 pack-year history if there is an additional cumulative risk of developing lung cancer of 5% or greater over the following 5 years. Lung cancer screening requires participation by a subspecialty-qualified team. The American Association for Thoracic Surgery will continue engagement with other specialty societies to refine future screening guidelines.

Conclusions: The American Association for Thoracic Surgery provides specific guidelines for lung cancer screening in North America.

Citing Articles

Evaluation of Surgical Cases of Lung Cancer Admitted in Shiraz Referral Hospitals, Southern Iran in 2009-2022.

Dehghani S, Rezvani A, Shahriarirad R, Rajabian M, Ziaian B, Fallahi M Cancer Rep (Hoboken). 2025; 8(3):e70108.

PMID: 40071520 PMC: 11897805. DOI: 10.1002/cnr2.70108.


MAEMC-NET: a hybrid self-supervised learning method for predicting the malignancy of solitary pulmonary nodules from CT images.

Zhao T, Yue Y, Sun H, Li J, Wen Y, Yao Y Front Med (Lausanne). 2025; 12:1507258.

PMID: 40012977 PMC: 11861088. DOI: 10.3389/fmed.2025.1507258.


An early lung cancer diagnosis model for non-smokers incorporating ct imaging analysis and circulating genetically abnormal cells (CACs).

Ni R, Huang Y, Wang L, Chen H, Zhang G, Yu Y BMC Cancer. 2025; 25(1):124.

PMID: 39844169 PMC: 11756104. DOI: 10.1186/s12885-024-13268-5.


The potential high-risk population for lung cancer screening: determination of initial screening age and heterogeneity in histology and sex.

Chen K, Yin Y, Wang C, Zeng A, Fang X, Abuduwayiti A Transl Lung Cancer Res. 2024; 13(11):2880-2889.

PMID: 39670011 PMC: 11632419. DOI: 10.21037/tlcr-24-475.


Current Evidence for a Lung Cancer Screening Program.

Guerreiro T, Aguiar P, Araujo A Port J Public Health. 2024; 42(2):133-158.

PMID: 39469231 PMC: 11498919. DOI: 10.1159/000538434.